Revance Releases Third Quarter 2017 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LEN
8. USO
9. LMT
10. TLT

Go back to Revance Releases Third Quarter 2017 Results

Revance Therapeutics (RVNC) Misses Q3 EPS by 8c

November 2, 2017 4:53 PM EDT

Revance Therapeutics (NASDAQ: RVNC) reported Q3 EPS of ($1.01), $0.08 worse than the analyst estimate of ($0.93). Revenue for the quarter came in at $75 thousand versus the consensus estimate of $50 thousand.

2017 Financial Outlook

Revance reaffirmed its financial guidance provided in January 2017. Revance expects cash... More